You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Automated Coding of Interaction Processes

    SBC: Idea Works Inc            Topic: N/A

    This study will test the feasibility of alternative machine learning strategies for training an expert decision support computer program to automatically code social interaction processes. Collecting and analyzing interaction process data is difficult, time consuming, and expensive. Reliability and reproducibility are difficult to establish and maintain. Phase I will test several alternative machi ...

    SBIR Phase I 1993 Department of Health and Human Services
  2. BIOABSORBABLE GLASS FOR RADIATION TREATMENT OF ARTHRITIS

    SBC: MO-SCI Corp.            Topic: N/A

    PRESENT TREATMENT OF RHEUMATOID ARTHRITIS IS PERFORMED BY SEVERAL METHODS, WHICH INCLUDE ANTI-INFLAMMATORY AGENTS, STEROIDS, IMMUNOSUPPRESSIVE AND CYTOTOXIC AGENTS, RADIATION TREATMENT BY BEAM METHOD, AND SURGERY. EACH METHOD HAS ITS DRAWBACKS. OF THESE METHODS, RADIATION BEAM TREATMENT HAS BEEN SHOWN TO SUPPRESS THE INFLAMED SYNOVIUM AND PALLIATE THE PATIENT'S PAIN. THERE ARE, HOWEVER, ADVERSE EF ...

    SBIR Phase II 1993 Department of Health and Human Services
  3. Bioactive Calcium Phosphate Glasses for Hyperthermia

    SBC: MO-SCI Corp.            Topic: N/A

    A new family of bioactive iron calcium phosphate glasses will be evaluated as thermoseeds for hyperthermia of cancers, especially bone tumors. Through appropriate heat treatment and atmosphere control, the Fe3+/Fe2+ ratio can be adjusted to achieve the desired magnetic hysteresis. The heat generating characteristics of these glasses under external magnetic induction will be studied as a function o ...

    SBIR Phase I 1993 Department of Health and Human Services
  4. Synthetic Glycoamines as Antimetastatic Drugs

    SBC: Laboratorytory And Environm            Topic: N/A

    The objective of Phase I is to select a small number (3 - 5) of synthetic compounds with high biological activities as inhibitors of cancer cell aggregation, adhesion, detachment and spreading (motility). These compounds will be selected from a panel of 20 currently available synthetic structural analogs of glycoamines. Glycoamines are a recently discovered new family of endogenous amino acid-suga ...

    SBIR Phase I 1993 Department of Health and Human Services
  5. SYNTHESES OF 13C-LABELED POLYUNSATURATED FATTY ACIDS

    SBC: Le Research, Inc.            Topic: N/A

    A NUMBER OF POLYUNSATURATED FATTY ACIDS (PUFA) ARE EITHER ESSENTIAL FOR A NORMAL DEVELOPMENT OF THE HUMAN BODY OR POTENTIAL PROPHYLACTIC/THERAPEUTIC AGENTS FOR ATHEROSCLEROSIS, RHEUMATOID ARTHRITIS, CARCINOGENESIS, TYPE I DIABETES, PREMATURE BIRTH AND LOW BIRTH-WEIGHT, AND ABNORMAL DEVELOPMENT OF THE CNS AND VISUAL ACUITY IN NEWBORNS. 13C-LABELED PUFA ARE OF INTEREST FOR METABOLIC AND IN VIVO 13C ...

    SBIR Phase II 1993 Department of Health and Human Services
  6. Regulators of Fibroblast Growth Factor Activity

    SBC: RELIABLE BIOPHARMACEUTICAL CORPORATION            Topic: N/A

    TELEPHONE NUMBER: (314) 429-7700 AWARDEE NUMBER: 1 R43 CA61390-01 The overall objective is to develop polysulfated carbohydrate derivatives that will inhibit the action of fibroblast growth factors (FGF). FGF's have been implicated in several human cancers both as angiogenic factors and as growth factors capable of sustaining autonomous cell proliferation. Inhibition of these growth factors could ...

    SBIR Phase I 1993 Department of Health and Human Services
  7. Synthesis of Oxidant-Free Potassium Lactobionate

    SBC: RELIABLE BIOPHARMACEUTICAL CORPORATION            Topic: N/A

    The overall objective is to develop a process to produce lactobionic acid that is free of oxidizing components. Lactobionic acid is an essential component of perfusion solutions used to preserve organs for transplantation (Sumimoto, 1990). It functions as an impermeant and calcium chelator as well as a reducing agent. These solutions also contain other reducing components such as glutathione which ...

    SBIR Phase I 1993 Department of Health and Human Services
  8. Facial 3D Surface Scanner for Facial Plastic Surgery

    SBC: Rose Imaging            Topic: N/A

    There is no established non-contact method to quantify surface morphology or edema and objectively assess change resulting from facial reconstructive or cosmetic plastic surgery. We will develop and test a quantification technique based on a three dimensional, non-contact, optical range sensing device, originally developed for commercial portrait sculpture and adapted for medical use. This techniq ...

    SBIR Phase I 1993 Department of Health and Human Services
  9. Multimedia and Kids¿Be Tobacco-Free to Reduce Cancer Risk

    SBC: Software Systems Specialists,            Topic: N/A

    We will develop a computer-based training system for fourth through sixth graders which presents factual information in an engaging and enjoyable manner. The system will incorporate advanced computing technologies, interactive multimedia, hypertext, and simulation to maximize learning in a flexible computing environment. Specific objectives include developing a prototype and evaluating its effecti ...

    SBIR Phase I 1993 Department of Health and Human Services
  10. Algorithms for Pigmented Lesion Screening and Detection

    SBC: William V. Stoecker And            Topic: N/A

    The study addresses the need for better physician training by providing specific accurate clinical descriptions of pigmented lesions including malignant melanoma. In Phase I, we will develop clinical algorithms to precisely describe malignant melanoma. In this phase, our aims include 1) location of early melanomas within the melanoma color band, definition of variegation, precise color description ...

    SBIR Phase I 1993 Department of Health and Human Services
US Flag An Official Website of the United States Government